Diagnostic and prognostic value of leptin as a marker of cardiometabolic risk
DOI:
https://doi.org/10.14739/2310-1237.2012.2.16579Keywords:
leptin, metabolic comorbid conditions, cardiovascular risk, the overall mortality, survival, prognosisAbstract
This review discusses the diagnostic and prognostic value of leptin in the assessment of an individual cardiometabolic risk. The article provides information about basic experimental and clinical studies on this topic. Attention is paid to debated questions of relationship between circulating levels of leptin and the magnitude of cardiovascular morbidity and mortality in different populations.
References
Чубенко А.Е. Лептин и метаболический синдром / Чубенко А.Е., Беляева О.Д., Беркович О.А., Баранова Е.И. // Росс. Физиол. журн. – 2010. – №96 (10). – Р. 945–965
Aizawa-Abe M. Ob gene / Aizawa-Abe M., Ogawa Y., Masuzaki H., Nakao K. // Nihon Rinsho. – 2000. – №58, Suppl 1. – Р. 551–555.
Alberti K.G. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity / Alberti K.G., Eckel R.H., Grundy S.M. et al. // Circulation. – 2009. – №120 (16). – Р. 1640–1645.
Arai Y. Adipokines and aging / Arai Y., Takayama M., Abe Y., Hirose N. // J Atheroscler. Thromb. – 2011. – №18 (7). – Р. 545–550.
Asahara N. Leptin, high molecular weight adiponectin / Asahara N. // Nihon Rinsho. – 2011. – №69, Suppl 1. – Р. 507–511.
Azadbakht L. A cross-over trial on soy intake and serum leptin levels in women with metabolic syndrome / Azadbakht L., Esmaillzadeh A. // J Res Med Sci. – 2010. – №15 (6). – Р. 317–323.
Basoglu O.K. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome / Basoglu O.K., Sarac F., Sarac S., Uluer H., Yilmaz C. // Ann Thorac Med. – 2011. – №6 (3). – Р. 120–125.
Baudrand R. Increased urinary glucocorticoid metabolites are associated with metabolic syndrome, hypoadiponectinemia, insulin resistance and β cell dysfunction / Baudrand R., Campino C., Carvajal C.A., Olivieri O., Guidi G., Faccini G., Sateler J., Cornejo J., Martin B.S., Dominguez J.M., Cerda J., Mosso L.M., Owen G.I., Kalergis A.M., Fardella C.E. // Steroids. – 2011. – Oct 5. [Epub ahead of print].
Bełtowski J. Leptin and the regulation of endothelial function in physiological and pathological conditions / Bełtowski J. // Clin. Exp. Pharmacol. Physiol. – 2012. – №39 (2). – Р. 168–178.
Boguszewski C.L. Neuroendocrine body weight regulation: integration between fat tissue, gastrointestinal tract, and the brain / Boguszewski C.L., Paz-Filho G., Velloso L.A. // Endokrynol. Pol. – 2010. – №61 (2). – Р. 194–206.
Borel J.C. Noninvasive Ventilation in Mild obesity hypoventilation syndrome: A randomized controlled trial / Borel J.C., Tamisier R., Gonzalez-Bermejo J., Baguet J.P., Monneret D., Arnol N., Roux-Lombard P., Wuyam B., Levy P., Pepin J.L. // Chest. – 2012. – №141 (3). – Р. 692–702.
Bray G.A. The MONA LISA hypothesis in the time of leptin / Bray G.A., York D.A. // Recent Prog Horm Res. – 1998. – №53. – Р. 95–117.
Carroll P.A. Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer / Carroll P.A., Healy L., Lysaght J., Boyle T., Reynolds J.V., Kennedy M.J., Pidgeon G., Connolly E.M. // Mol. Carcinog. – 2011. – №50 (8). – Р. 643–651.
De Luis D.A. Lys656Asn polymorphism of leptin receptor gene and metabolic syndrome in obese patients / De Luis D.A., Gonzalez Sagrado M., Aller R., Izaola O., Conde R., Castro M.J. // Eur. Rev. Med. Pharmacol. Sci. – 2011. – №15 (5). – Р. 463–468.
DeFronzo R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 / DeFronzo R.A. // Diabetologia. – 2010. – №53 (7). – Р. 1270–1287.
Carmo J.M. Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons / Carmo J.M., da Silva A.A., Cai Z., Lin S., Dubinion J.H., Hall J.E. // Hypertension. – 2011. – №57 (5). – Р. 918–926.
Enns J.E. Variations in Adipokine Genes AdipoQ, Lep, and LepR are Associated with Risk for Obesity-Related Metabolic Disease: The Modulatory Role of Gene-Nutrient Interactions / Enns J.E., Taylor C.G., Zahradka P. // J. Obes. – 2011. – 168659.
Enriori P.J. Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance / Enriori P.J., Sinnayah P., Simonds S.E., Garcia Rudaz C., Cowley M.A. // J. Neurosci. – 2011. №31 (34). – Р. 12189–12197.
Esteghamati A. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects / Esteghamati A., Noshad S., Khalilzadeh O., Morteza A., Nazeri A., Meysamie A., Esteghamati A., Nakhjavani M. // Arch. Med. Res. – 2011. – №42 (3). – Р. 244–251.
Esteghamati A. Leptin cut-off values for determination of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007) / Esteghamati A., Zandieh A., Zandieh B., Khalilzadeh O., Meysamie A., Nakhjavani M., Gouya M.M. // Endocrine. – 2011. – №40 (1). – Р. 117–123.
Farooqui A.A. Metabolic syndrome as a risk factor for neurological disorders / Farooqui A.A., Farooqui T., Panza F., Frisardi V. // Cell. Mol. Life Sci. – 2011. – Oct 15. [Epub ahead of print].
Frühbeck G. Relation between leptin and the regulation of glucose metabolism / Frühbeck G., Salvador J. // Diabetologia. – 2000. – №43 (1). – Р. 3–12.
Fukuhara A. Adiponectin, leptin, adipsin / Fukuhara A., Otsuki M., Shimomura I. // Nihon Rinsho. – 2011. – №69, Suppl 1. – Р. 221–224.
Garcia-Mayor R.V. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage / Garcia-Mayor R.V., Andrade M.A., Rios M., Lage M., Dieguez C., Casanueva F.F. // J. Clin. Endocrinol Metab. – 1997. – №82 (9). – Р. 2849–2855.
Gonzalez-Bulnesa A. Ovulation, Implantation and Placentation in Females with Obesity and Metabolic Disorders: Life in the Balance. Endocr. Metab. Immune Disord / Gonzalez-Bulnesa A., Pallaresa P., Ovilob C. // Drug Targets. – 2011. – №11 (4). – Р. 285–301.
Gormez S. Adipose tissue gene expression of adiponectin, tumor necrosis factor-α and leptin in metabolic syndrome patients with coronary artery disease / Gormez S., Demirkan A., Atalar F., Caynak B., Erdim R., Sozer V., Gunay D., Akpinar B., Ozbek U., Buyukdevrim A.S. // Intern. Med. – 2011. – №50 (8). – Р. 805–810.
Gupta A. Association between circulating leptin and insulin resistance, the lipid profile, and metabolic risk factors in North Indian adult women / Gupta A., Gupta V., Agrawal S., Natu S.M., Agrawal C.G., Negi M.P., Tiwari S. // Biosci Trends. – 2010. – №4 (6). – Р. 325–332.
Hahn S. Leptin. Neuroendocrine Wirkung und Einflüsse auf den menstruallen Zyklus / Hahn S., Tan S., Janssen O.E. // Gynecol Endocrinol. – 2006. – №4 (1). – Р. 33–38.
Hall J.I. Leptin/adiponectin ratio in patients with coronary heart disease: comparing subjects with and without metabolic syndrome / Hall J.I., Vora N., Langworthy R., Stock S., Momin A., Sherwood R.A., le Roux C.W., Alaghband-Zadeh J. // Ann Clin Biochem. – 2011. – №48 (Pt 4). – Р. 327–331.
Hassink S.G. Serum leptin in children with obesity: relationship to gender and development / Hassink S.G., Sheslow D.V., de Lancey E., Opentanova I., Considine R.V., Caro J.F. // Pediatrics. – 1996. – №98 (2 Pt 1). – Р. 201–203.
Healy L. Metabolic syndrome and Leptin are Associated with Adverse Pathological Features in Male Colorectal Cancer Patients / Healy L., Howard J., Ryan A., Beddy P., Mehigan B., Stephens R., Reynolds J. // Colorectal Dis. – 2012. – №14 (2). – Р. 157–165.
Hong H.R. Clustering of metabolic syndrome risk factors associated with lifestyle factors and serum leptin in Korean children / Hong H.R., Cho J.K., Lee J.Y., Park J.K., Kang H.S. // Pediatr. Exerc. Sci. – 2011. – №23 (2). – Р. 270–280.
Horigome H. Significant associations among hemostatic parameters, adipokines, and components of the metabolic syndrome in Japanese preschool children / Horigome H., Katayama Y., Yoshinaga M., Kato Y., Takahashi H., Sumazaki R. // Clin. Appl. Thromb. Hemost. – 2012. – №18 (2). – Р. 189–194.
Howard J.K. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haplinsufficiency of Socs3 / Howard J.K., Cave B.J., Oksanen L.J., Tzameli L., Bjorbaek C., Flier J.S. // Nat. Med. – 2004. – №10 (10). – Р. 734–738
Kajikawa Y. Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors / Kajikawa Y., Ikeda M., Takemoto S., Tomoda J., Ohmaru N., Kusachi S. // Int. Heart J. – 2011. – №52 (1). – Р. 17–22.
Kotani K. Leptin:adiponectin ratio and metabolic syndrome in the general Japanese population / Kotani K., Sakane N. // Korean J Lab Med. – 2011. – №31 (3). – Р. 162–166.
Larsson H. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women / Larsson H., Elmståhl S., Ahrén B. // Diabetes. – 1996. – №45 (11). – Р. 1580–1584.
Lecke S.B. Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome / Lecke S.B., Mattei F., Morsch D.M., Spritzer P.M. // Fertil. Steril. – 2011. – №95 (6). – Р. 2044–2049.
Li W.C. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults / Li W.C., Hsiao K.Y., Chen I.C., Chang Y.C., Wang S.H., Wu K.H. // Cardiovasc Diabetol. – 2011. – №10. – Р. 36.
Lin Y.H. Plasma leptin levels and digital pulse volume in obese patients without metabolic syndrome – a pilot study / Lin Y.H., Ho Y.L., Lee J.K., Huang H.L., Huang K.C., Chen M.F. // Clin. Chim. Acta. – 2011. – №412 (9–10). – Р. 730–734.
Lord G.M. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression / Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., Lechler R.I. // Nature. – 1998. – №394 (6696). – Р. 897–901.
Mirza S. Adiponectin/leptin ratio and Metabolic Syndrome in a Mexican American population / Mirza S., Qu H.Q., Li Q., Martinez P.J., Rentfro A.R., McCormick J.B., Fisher-Hoch S.P. // Clin Invest Med. – 2011. – №34 (5). – E290.
Montague C.T. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution / Montague C.T., Prins J., Sanders B. et al. // Diabetes. – 1997. – №46. – Р. 342–347.
Moran O. Leptin: obesity, diabetes and other peripheral effects / Moran O., Phillip M. // Pediatr Diabetes. – 2003. – №4 (2). – Р. 101–109.
Nukitrangsan N. Effect of Peucedanum japonicum Thunb on the Expression of Obesity-Related Genes in Mice on a High-Fat Diet / Nukitrangsan N., Okabe T., Toda T., Inafuku M., Iwasaki H., Yanagita T., Oku H. // J Oleo Sci. – 2011. – №60 (10). – Р. 527–536.
Pallett A.L. Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets / Pallett A.L., Morton N.M., Cawthorne M.A., Emilsson V. // Biochem. Biophys. Res. Commun. – 1997. – №238 (1). – Р. 267–270.
Papoutsakis C. Metabolic syndrome in a Mediterranean pediatric cohort: prevalence using International Diabetes Federation-derived criteria and associations with adiponectin and leptin / Papoutsakis C., Yannakoulia M., Ntalla I., Dedoussis G.V. // Metabolism. – 2012. – №61 (2). – Р. 140–145.
Rahmouni K. Intracellular mechanisms involved in leptin regulation of sympathetic outflow / Rahmouni K., Haynes W.G., Morgan D.A., Mark A.L. // Hypertension. – 2003. – №41 (3 Pt 2). – Р. 763–767.
Rao F. Genetic Variation Within a Metabolic Motif in the Chromogranin A Promoter: Pleiotropic Influence on Cardiometabolic Risk Traits in Twins / Rao F., Chiron S., Wei Z., Fung M.M., Chen Y., Wen G., Khandrika S., Ziegler M.G., Benyamin B., Montgomery G, Whitfield J.B., Martin N.G., Waalen J., Hamilton B.A., Mahata S.K., O’Connor D.T. // Am J Hypertens. – 2012. – №25 (1). – Р. 29–40.
Ronti T. The endocrine function of adipose tissue: an update / Ronti T., Lupattelli G., Monnarino E. // Clin. Endocrinol. – 2006. – №64. – Р. 355–365.
Saad M.F. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity / Saad M.F., Riad-Gabriel M.G., Khan A., Sharma A., Michael R., Jinagouda S.D., Boyadjian R., Steil G.M. // J. Clin. Endocrinol. Metab. – 1998. – №83 (2). – Р. 453–459.
Sánchez-de-la-Torre M. The influence of obesity and obstructive sleep apnea on metabolic hormones / Sánchez-de-la-Torre M., Mediano O., Barceló A., Piérola J., de la Peña M., Esquinas C., Miro A., Durán-Cantolla J., Agustí A.G., Capote F., Marin J.M., Montserrat J.M., García-Río F., Barbé F. // Sleep Breath. – 2011. – Sep 13. [Epub ahead of print]
Sari R. The relationship between plasma leptin levels and chronic complication in patients with type 2 diabetes mellitus / Sari R., Balci M.K., Apaydin C. // Metab. Syndr. Relat. Disord. – 2010. – №8 (6). – Р. 499–503.
Scuteri A. Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study / Scuteri A., Orru M., Morrell C., Piras M.G., Taub D., Schlessinger D., Uda M., Lakatta E.G. // Atherosclerosis. – 2011. – №215 (2). – Р. 459–464.
Shigemura N. Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures / Shigemura N., Ohta R., Kusakabe Y., Miura H., Hino A., Koyano K., Nakashima K., Ninomiya Y. // Endocrinology. – 2004. – №145 (2). – Р. 839–847.
Sierra-Honigmann M.R. Biological action of leptin as an angiogenic factor / Sierra-Honigmann M.R., Nath A.K., Murakami C., García-Cardeña G., Papapetropoulos A., Sessa W.C., Madge L.A., Schechner J.S., Schwabb M.B., Polverini P.J., Flores-Riveros J.R. // Science. – 1998. – №281 (5383). – Р. 1683–1686.
Toda C. Mechanism of dysregulated energy homeostasis in metabolic syndrome / Toda C. // Nihon. Rinsho. – 2011. – №69, Suppl 1. – Р. 133–137.
Vuagnat B.A. Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat / Vuagnat B.A., Pierroz D.D., Lalaoui M., Englaro P., Pralong F.P., Blum W.F., Aubert M.L. // Neuroendocrinology. – 1998. – №67 (5). – Р. 291–300.
Wang S.N. Leptin in hepatocellular carcinoma / Wang S.N., Lee K.T., Ker C.G. // World J Gastroenterol. – 2010. – №16 (46). – Р. 5801–5809.
Wiwanitkit S. Insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein and metabolic syndrome / Wiwanitkit S., Wiwanitkit V. // Ann. Thorac Med. – 2011. – №6 (4). – Р. 243.
Younus S. Biomarkers associated with cardiometabolic risk in obesity / Younus S., Rodgers G. // Am. Heart Hosp. J. – 2011. – №9 (1). – E28–32.
Yun J.E. Association of the leptin to high-molecular-weight adiponectin ratio with metabolic syndrome / Yun J.E., Won S., Mok Y., Cui W., Kimm H., Jee S.H. // Endocr. J. – 2011. – №58 (9). – Р. 807–815.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
